Biodermis Introduces Mia Breast Forms
LAS VEGAS (PRWEB) January 25, 2018 -- MIA® is a brand of prosthetic breast forms, created by women for women, with a mission centered on helping women achieve their ideal post-surgical silhouette following mastectomy (breast removal) surgery. MIA® donates 2% of sales to breast cancer foundations dedicated to educating and supporting women facing breast cancer.
To address the variety of mastectomy outcomes, Biodermis will launch the product line with two distinct shapes; the Mia Anatomical, and Mia Triangular.
Mia Anatomical has a teardrop shape, and is recommended for radical or complete mastectomy procedures, where all of the breast tissue has been removed. The tapered top may be positioned in any direction that provides an optimal fit. Mia Triangular is recommended for partial mastectomies, where only a portion of the breast tissue is removed. It is designed for correcting asymmetry issues resulting from the removal of only part of the breast. Both the Mia Anatomical and Triangular breast forms are symmetrical, for use on either the right or left side. There are many cases were a mastectomy patient requires either a single prosthesis, or an anatomical shape for one side, and a triangular shape for the other side. The Mia line addresses the majority of mastectomy outcomes.
“Biodermis has been providing mastectomy-specific scar care products for nearly 30 years. With the addition of the Mia breast forms, we are now able to provide women with a complete post-surgical solution."
— Jeff Schleuning, Ph.D.
Partner, Biodermis
Mia Breast Forms from Biodermis will be available online through Biodermis at biodermis.com and through Amazon at amazon.com.
Established in 1988, Biodermis has been recognized for its innovative contributions to the scar management, post-operative and skincare industries for nearly 30 years. For more information regarding Mia breast forms, log on at biodermis.com or call (702) 260-4466.
Sean Mahoney, Biodermis, http://biodermis.com, +1 (702) 260-4466, [email protected]
Share this article